Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Clin Pharmacokinet. 2018 Feb;57(2):125–149. doi: 10.1007/s40262-017-0569-6

Fig. 4.

Fig. 4

Linear regression of remifentanyl clearance and bodyweight in children including neonates (R2=0.69, solid grey line). Allometric function of remifentanil clearance and bodyweight in children neonates (R2=0.72, dotted black line).